13F Data
13F filer · CIK 1901930

H&F Corporate Investors X, Ltd.

San Francisco, CA · filing since Q1 2022 · last filing Aug 12, 2026
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Reported value
$2.8B
$-1.1B vs prior
Positions
1
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $615.2M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedMEDLINE INC-15,599,171-18.0%$-615.2M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q1 2022: $1.8BQ2 2022: $1.1BQ3 2022: $962.5MQ4 2022: $1.1BQ1 2023: $1.2BQ2 2023: $1.4BQ3 2023: $1.9BQ4 2023: $2.0BQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $4.2BQ1 2026: $3.8BQ2 2026: $2.8B
Q1 2022Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1MEDLINE INCCOM CL A70,874,326$2.8B100.00%